Suggestions
Yoav Manaster
CEO at Progenetics, Co-Founder at EdiTy Therapeutics
Yoav Manaster is a highly qualified individual with a deep understanding of tumor immunology, holding two Doctor of Philosophy (Ph.D.) degrees from the prestigious Weizmann Institute of Science.
His professional journey includes the role of Co-Founder at EdiTy Therapeutics, a cutting-edge organization focused on therapeutic innovations, showcasing his entrepreneurial spirit and leadership capabilities.
Prior to his current venture, Yoav Manaster served as the CEO at Progenetics, contributing to his versatile experience in the biotechnology and healthcare sectors.